RT期刊文章SR电子T1文化肺动脉导管肺动脉内皮细胞的气球提示:考虑用于肺血管疾病摩根富林明欧洲呼吸杂志乔和J FD欧元欧洲呼吸学会SP 1901313 10.1183/13993003.01313 -2019 A1科里大肠Ventetuolo A1杰森·m·Aliotta A1朱莉Braza A1 Havovi Chichger A1马克内尔A1唐纳德McGuirl A1克里斯托弗·J·穆林A1朱莉牛顿A1曼迪佩雷拉A1艾米Princiotto A1 Pete188bet官网地址r J . Quesenberry A1托马斯·沃尔什A1玛丽Whittenhall A1詹姆斯·r·科林格A1伊丽莎白·o·哈林顿年2020 UL //www.qdcxjkg.com/content/early/2019/12/12/13993003.01313 - 2019. -抽象AB内皮功能障碍的一个特点是肺动脉高血压(PAH)但没有建立方法研究肺动脉内皮细胞(PAECs)从生活的病人。我们寻求文化PAECs肺动脉导管(PAC)气球中使用正确的心脏catheterisation (RHC),描述成功的文化,试图描述PAEC行为。PAECs主要生长在文化融合和内皮细胞表型确认。标准检测细胞凋亡、迁移和管形成通道3 - 8之间进行。我们收集49 PAC技巧来自45个科目与成功PAEC文化从19(39%)气球。没有主题的人口差异或RHC程序细节成功与失败。有更高的成功但无意义的比例(10/19,53%)和不成功(9/30,30%)尝试从受试者符合血流动力学标准多环芳烃(p = 0.10)。成功的文化更可能在较低的受试者心脏指数(p = 0.03)和更高的肺血管阻力(p = 0.04)。PAECs从主题与特发性肺动脉高压抗凋亡相比商业PAECs (p = 0.04),减少迁移PAECs相比,从一个主题portopulmonary高血压与高心输出量(p = 0.01)。PAECs与艾滋病毒相关主题多环芳烃形成少(p = 0.01)和短(p = 0.02)船网络商业PAECs相比。持续的文化和人物塑造的PAECs RHC气球是可行的,特别是在多环芳烃高血流动力学的负担。这种技术可以提供洞察PAH发病期间内皮功能障碍。FootnotesThis manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.Conflict of interest: Dr. Ventetuolo reports grants from National Institutes of Health , during the conduct of the study; grants from United Therapeutics and Eiger to her institution, personal fees from Acceleron Pharma, outside the submitted work; and Spouse is an employee of CVS Health.Conflict of interest: Dr. Aliotta has nothing to disclose.Conflict of interest: Dr. Braza has nothing to disclose.Conflict of interest: Dr. Chichger has nothing to disclose.Conflict of interest: Dr. Dooner has nothing to disclose.Conflict of interest: Dr. McGuirl has nothing to disclose.Conflict of interest: Dr. Mullin has nothing to disclose.Conflict of interest: Dr. Newton has nothing to disclose.Conflict of interest: Dr. Pereira has nothing to disclose.Conflict of interest: Dr. Princiotto has nothing to disclose.Conflict of interest: Dr. Quesenberry has nothing to disclose.Conflict of interest: Dr. Walsh has nothing to disclose.Conflict of interest: Dr. Whittenhall has nothing to disclose.Conflict of interest: Dr. Klinger has nothing to disclose.Conflict of interest: Dr. Harrington has nothing to disclose.